Radiation therapy after surgery for breast phyllodes tumors
Part of Cancer clinical trials.
This study tests whether giving radiation therapy after surgery, based on the tumor's molecular subtype, can reduce the chance of the tumor coming back in women with borderline or malignant phyllodes tumors of the breast.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 75 years old.
- You have been diagnosed with a borderline or malignant phyllodes tumor of the breast, with a specific molecular subtype (MN1 or MN2).
- You have had surgery to remove the tumor with clean margins, and it's been within the last 16 weeks.
- The tumor has not spread to other parts of your body (no distant metastases).
- You are generally in good health (able to do daily activities) and can give informed consent.
- You have not had radiation to the same breast or chest before, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests a specific plan that combines chemotherapy (and sometimes targeted medicines) with radiation before surgery for one breast. It may help shrink breast cancer and improve treatment timing, based on how well tumors respond.
This study tests whether giving radiation after breast surgery can improve outcomes for people with breast cancer that has spread to nearby lymph nodes (N1). You may be a candidate if you’ve already had surgery and meet specific details about your lymph nodes and cancer type.
This trial studies whether giving radiotherapy after a mastectomy helps prevent breast cancer coming back in women whose lymph nodes are not involved (or only very tiny spread). It may help reduce recurrence risk, especially for patients with higher-risk features despite node-negative early cancer.
This Phase 2 trial looks at a specific radiation timing and technique around the time of breast-conserving surgery. It may help reduce the chance the cancer comes back in selected older patients with certain early-stage, hormone-positive, HER2-negative breast cancers.
This trial looks at whether adding targeted radiation to lymph nodes after breast surgery can lower the chance of breast cancer coming back in people with higher-risk, node-negative disease. If you qualify, you may get a planned radiation approach designed for prevention, not treatment of spread.
This study looks at whether adding extra targeted radiation to the tumor area before breast-conserving surgery, then using modern breast surgery techniques and whole-breast radiation afterward, improves outcomes for early-stage breast cancer. You may be offered a treatment plan designed to better treat the area where the tumor was removed.
Hear when a new Radiotherapy, Adjuvant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.